TRY 4.48
(1.82%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.13 Billion | 2.65 Billion | 2 Billion | 2.48 Billion | 2.58 Billion | 2.09 Billion |
Net Income | 10.71 Billion | 39.99 Million | -159.43 Million | 38.2 Million | -157.92 Million | 5.01 Million |
Depreciation & Amortization | 4.29 Billion | 1.48 Billion | 690.59 Million | 603.29 Million | 517.63 Million | 459.09 Million |
Deferred income taxes | - | -204.31 Million | -129.38 Million | -11.32 Million | 21.1 Million | -108.67 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 9.47 Billion | -1.93 Billion | -651.34 Million | 291.63 Million | 625.37 Million | 594.63 Million |
Other non-cash items | -21.93 Billion | 3.07 Billion | 2.12 Billion | 1.55 Billion | 1.6 Billion | 1.03 Billion |
Investing Cash Flow | -190.17 Million | -527.23 Million | -269.58 Million | -609.66 Million | -1.02 Billion | -779.47 Million |
Investments in PPE | -1.02 Billion | -522 Million | -340.15 Million | -303.64 Million | -151.28 Million | -656.63 Million |
Acquisitions | 922.33 Million | -14.65 Million | 4.79 Million | 72.1 Million | 29.54 Million | -92 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -83.11 Million | 9.42 Million | 65.78 Million | -378.12 Million | -905.3 Million | -30.84 Million |
Financing Cash Flow | -6.65 Billion | -953.72 Million | -1.16 Billion | -1.86 Billion | -1.17 Billion | -1.08 Billion |
Debt repayment | -7.57 Billion | -5.81 Billion | -5.07 Billion | -3.23 Billion | -2.14 Billion | -2.32 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.33 Billion | 1.95 Billion | 194.09 Million | - | - | - |
Other Financing Activities | -267.89 Million | 4.85 Billion | 3.71 Billion | 1.37 Billion | 965.44 Million | 1.24 Billion |
Accounts receivables | 14.04 Billion | -5.96 Billion | -998.22 Million | 471.92 Million | -23.54 Million | 362.37 Million |
Accounts payables | -3.21 Billion | 3.53 Billion | 220.5 Million | -342 Million | 570.92 Million | 207.17 Million |
Inventory | 331.37 Million | -271.28 Million | -96.73 Million | -6.45 Million | -2.88 Million | 7.07 Million |
Other working capital | -1.68 Billion | 765.41 Million | 223.1 Million | 168.17 Million | 80.87 Million | 587.55 Million |
Cash at beginning of period | 3.79 Billion | 1.16 Billion | 709.9 Million | 823.12 Million | 582.68 Million | 352.45 Million |
Cash at end of period | 1.93 Billion | 2.29 Billion | 1.16 Billion | 709.9 Million | 823.02 Million | 582.68 Million |
Capital Expenditure | -1.02 Billion | -522 Million | -340.15 Million | -303.64 Million | -151.28 Million | -656.63 Million |
Effect of forex changes on cash | -146.59 Million | -44.49 Million | -117.33 Million | -130.28 Million | -143.55 Million | -45.61 Million |
Net cash flow / Change in cash | -1.86 Billion | 1.13 Billion | 451.73 Million | -113.21 Million | 240.34 Million | 230.22 Million |
Free Cash Flow | 4.1 Billion | 2.13 Billion | 1.66 Billion | 2.18 Billion | 2.43 Billion | 1.43 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.37 Billion | 3.51 Billion | 10.71 Billion | 8.57 Billion | 157.74 Million | 428.51 Million |
Depreciation & Amortization | 794.94 Million | 1.16 Billion | 4.29 Billion | 2.51 Billion | 593.1 Million | 592.43 Million |
Deferred income taxes | -1.07 Billion | -823.21 Million | - | -614.58 Million | 1.09 Billion | -536.53 Million |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 3.89 Billion | 2.84 Billion | 9.47 Billion | 9.34 Billion | -475.89 Million | -238.79 Million |
Other non-cash items | -3.42 Billion | -3.77 Billion | -21.93 Billion | -23.72 Billion | 1.75 Billion | 1.37 Billion |
Investing Cash Flow | 224.68 Million | 3.56 Billion | -190.17 Million | -465.36 Million | -18.45 Million | -296.33 Million |
Investments in PPE | -198.93 Million | -142.54 Million | -1.02 Billion | -476.87 Million | -129.57 Million | -238.68 Million |
Acquisitions | 423.62 Million | 3.56 Billion | 922.33 Million | 11.5 Million | - | 927.59 Million |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 414.55 Million | 3.69 Billion | -83.11 Million | -44.11 Million | 111.12 Million | -985.24 Million |
Financing Cash Flow | -587.62 Million | -7.02 Billion | -6.65 Billion | -2.98 Billion | -2.33 Billion | -1.08 Billion |
Debt repayment | -958.58 Million | -4.8 Billion | -7.57 Billion | -2.61 Billion | -2.66 Billion | -1.49 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | 1.33 Billion | 4.61 Million | 399.36 Million | 631.9 Million |
Other Financing Activities | 347.07 Million | 269.59 Million | -267.89 Million | -305.2 Million | -77.24 Million | -222.6 Million |
Accounts receivables | 3.72 Billion | 3.93 Billion | 14.04 Billion | 12.73 Billion | 437.39 Million | 699.32 Million |
Accounts payables | -15.42 Million | -1.37 Billion | -3.21 Billion | -2.48 Billion | -205.13 Million | -957.73 Million |
Inventory | -65.09 Million | -79.83 Million | 331.37 Million | 787.25 Million | -91.02 Million | -288.98 Million |
Other working capital | 250.76 Million | 341.79 Million | -1.68 Billion | -1.68 Billion | -617.12 Million | 308.6 Million |
Cash at beginning of period | 1.01 Billion | 2.21 Billion | 3.79 Billion | 1.89 Billion | 2.05 Billion | 1.47 Billion |
Cash at end of period | 1.23 Billion | 995.46 Million | 1.93 Billion | 1.93 Billion | 1.86 Billion | 2.05 Billion |
Capital Expenditure | -198.93 Million | -142.54 Million | -1.02 Billion | -476.87 Million | -129.57 Million | -238.68 Million |
Effect of forex changes on cash | 13.25 Million | -57.17 Million | -146.59 Million | -81.81 Million | 139.32 Million | -194.87 Million |
Net cash flow / Change in cash | 225.95 Million | -1.21 Billion | -1.86 Billion | 37.06 Million | -191.37 Million | 580.29 Million |
Free Cash Flow | 662.78 Million | 2.15 Billion | 4.1 Billion | 1.63 Billion | 1.89 Billion | 1.91 Billion |
600703
8960
ORCHPHARMA
GRAVITA
NIKL
008930